Podcasts about Sapient

In this special edition of Retail Media Therapy, Viv and Colin unpack the biggest retail media deal of the year: Publicis Groupe's $2.2 billion acquisition of LiveRamp.Why would one of the world's largest agency groups buy one of the industry's most important data collaboration platforms? We explore what the deal means for retailers, brands, agencies and retail media networks, and whether this is really an AI play... or something much more fundamental.The conversation dives into LiveRamp's role as a neutral identity and clean-room provider, the strategic fit with Publicis assets such as Epsilon, Sapient and Marcel, and why identity resolution, data collaboration and measurement have become the industry's most valuable battlegrounds. Viv and Colin debate whether access to customer IDs is becoming more important than access to media inventory, and examine the growing importance of customer graphs in an AI-driven marketing landscape.They also discuss the challenges facing retail media networks and the potential risks to LiveRamp's neutrality now that it sits inside a major holding company. A must-listen for anyone trying to understand the future of retail media, identity and data-driven marketing.Grace & Co | Retail Media Experts Hosted on Acast. See acast.com/privacy for more information.

Deus Onipotente, Todo-Poderoso, Sapientíssimo, tinha que escolher sua Mãe. O que você teria feito se tivesse que escolher a tua mãe? Creio que você e eu teríamos escolhido a que temos, enchendo-a de todas as graças. Isso fez Deus. (...) Os teólogos fazem um raciocínio lógico desse cúmulo de graças, desse não estar submetida a Satanás: convinha, Deus podia fazê-lo, portanto fez. É a grande prova. A prova mais clara de que Deus rodeou a sua mãe de todos os privilégios desde o primeiro instante. E assim é formosa e pura e limpa na alma e no corpo (São Josemaria).

Tonight on Glick's House of Music, Glick welcomes Vk Lynne and David Ruiz from Sapient Scar do a no-holds-barred interview covering covering he music,the passion,and the chaos behind the band. Tune in and crank it loud. Live on The Nonsensical Network Glick's House of Music your unofficial backstage passFOLLOW US EVERYWHERE bio.link/nonsensicalnetworkSUPPORT THE SHOWS CASHAPP $glickglick13

Publicis dropped a bomb on Sunday. By Monday, LinkedIn was on fire. Christian, co-host of the In/organic Podcast pulled together two of the sharpest voices in commerce and media to break down what this deal actually means — beyond the press release.Joining In/Organic for this special episode: Ari Paparo, 20-year ad tech veteran, host of the Marketecture podcast, and author of Yield: How Google Bought, Built and Bullied Its Way to Advertising Dominance — and Peter (PVSB) Bond, co-host of the CPG Guys podcast (closing in on episode 600) and Head of Industry and Client Engagement at Flywheel, the commerce acceleration division of Omnicom.This is the one episode this week you can't skip.What we cover: Is this really an agentic AI story or is that just the packaging? Why LiveRamp's client count is already down from 940 to 800 — and what happens next. Why Omnicom, WPP, and every other holdco is immediately accelerating their own identity builds. The three distinct assets inside LiveRamp and which one actually matters. Why Amazon Marketing Cloud is the elephant in the clean room conversation. What independent agencies and lower middle market ad tech players should actually do in response. And who the M&A targets are for anyone not named Publicis.Timestamps0:00 — Breaking news: Publicis announces plan to acquire LiveRamp1:58 — Deal terms: $2.5B total EV, $2.16B net of cash, 2.8x revenue2:45 — Guest intros: Ari Paparo (Marketecture) and Peter Bond (CPG Guys / Flywheel)4:00 — The backstory: IPG acquired Acxiom in 2018 but deliberately excluded LiveRamp5:30 — Is this an agentic AI story? Ari's honest take7:30 — The agent execution problem: why data rails matter as much as intelligence8:43 — The MCP angle: data as enabler vs. data as action9:32 — Data supremacy and the holdco war — Peter's perspective11:00 — LiveRamp client attrition: 940 → 800 and Horizon already looking to exit11:35 — Auren Hoffman's forlorn X post and what's buried in it12:28 — What does WPP, Omnicom, and every other holdco do now?13:18 — Publicis's track record: Epsilon, Citrus Ad, Sapient — and whether Profiteur was worth it14:55 — Breaking down LiveRamp's three assets: Ramp ID, clean room (Habu), and onboarding16:30 — WPP acquired Infosum. Omnicom has Acxiom/Real ID. Who's missing what?17:38 — Amazon Marketing Cloud owns 75% of retail media ad dollars — what does that leave LiveRamp?19:33 — Benoit from Liquid Death: "Not having a clean room strategy in 2026 is malfeasance"20:35 — What this means for independent agencies and lower middle market ad tech players22:21 — LiveRamp as a natural monopoly — and why competitors now have a real window23:35 — The Flywheel parallel: neutrality ends the moment you're inside a holdco25:48 — M&A targets for the corps dev teams at PMG, Horizon, and the super-independents27:16 — The Trade Desk's UID2: worth billions as a standalone, invisible inside the DSP27:36 — The financial model of holdcos is fundamentally transforming — Peter's closing argument29:12 — Ari's final shout-out: Optimal as the leading independent clean room target

In this episode of Not Just Buildings, host Foster Garrett introduces the podcast's new name and previews upcoming Chamber events, including a Spring Job Fair and a Legislative Wrap-Up Breakfast. He then sits down with Phyllis Everett nurse practitioner and owner of Sapient Health Services who reflects on her 47-year nursing career and her integrative healthcare practice serving rural Bedford County. Phyllis talks about her team, home visit services, functional medicine approach, mental health care, and plans for a new facility in Lynch Station. She also brings up an important question for legislators regarding medical cannabis use and concealed carry permits.This podcast lives on Media Squatch+ Your home for local voices, live shows, and nonstop audio.Listen free: https://mediasquat.ch/plus

A CMO Confidential Interview with Dave Penski, CEO of Connected Media, formerly CEO of Publicis Media, COO of Publicis Groupe, and CEO of ZenithOptimedia. Dave shares perspective on how clients are managing through a challenging marketplace, how there's increasing "disruption" between consumers and advertisers, and why the future of media is based on "connected identity." Key topics include: why Publicis continues to invest in tech; why 2027 will bring increased challenges for marketers; how different business verticals are impacted by "the economic K curve;" and why sports is "as AI proof as it gets." Tune in to hear why you should know your customer as precisely as possible across all media types and thoughts on the potential impacts of gambling and NIL (Name, Image and Likeness) on the golden goose of sports. Dave Penski, CEO of Publicis Media (twice over) and former COO of Publicis Groupe, returns to CMO Confidential for a wide-ranging conversation with host Mike Linton on the forces reshaping marketing, media, and the agency business in 2026. Dave offers a rare economist's-eye view across verticals — from tariffs and consumer confidence to the K-economy, AI's real (and overhyped) impact on agencies, the in-housing cycle that never quite materialized as predicted, and why 2027 may be the toughest advertising year in recent memory.Topics covered: connected identity, Publicis' $12B investment thesis, creative and engineering transformation via AI, streaming consolidation, the fragmentation of sports viewing, gambling regulation, and the one piece of career advice Dave still gives every mentee.*This episode is brought to you by Scrunch . Learn more at scrunchai.com/cmo

A CMO Confidential Interview with Dave Penski, CEO of Connected Media, formerly CEO of Publicis Media, COO of Publicis Groupe, and CEO of ZenithOptimedia. Dave shares perspective on how clients are managing through a challenging marketplace, how there's increasing "disruption" between consumers and advertisers, and why the future of media is based on "connected identity." Key topics include: why Publicis continues to invest in tech; why 2027 will bring increased challenges for marketers; how different business verticals are impacted by "the economic K curve;" and why sports is "as AI proof as it gets." Tune in to hear why you should know your customer as precisely as possible across all media types and thoughts on the potential impacts of gambling and NIL (Name, Image and Likeness) on the golden goose of sports.In this episode of CMO Confidential, host Mike Linton sits down with Dave Penski, two-time CEO of Publicis Media and former COO of Publicis Groupe, for a wide-ranging conversation on the forces reshaping media, agencies, and marketing strategy. Dave offers a ground-level view from one of the largest holding companies in the world — covering everything from the fragmented ad marketplace and AI's real-world impact, to the K-economy, streaming consolidation, sports gambling risk, and what CMOs should be building toward in 2027.This episode covers:Why the current ad marketplace is volatile — and which verticals are feeling it mostPublicis's $12B+ investment thesis around connected identity (Epsilon, Mars United, influencer)The real story on agency insourcing: who wins, who loses, and what "outsourcing back out" looks likeWhere AI is actually delivering — creative production, media planning speed, and Sapient's engineering workThe K-economy, hollowing out of the middle class, and what it means for advertising spendStreaming consolidation: why the Paramount/Warner Bros. deal is a win for advertisersSports as the most AI-proof content — and why gambling regulation is a threat to the whole modelWhat CMOs should be investing in now to win in 2027New episodes of CMO Confidential drop every Tuesday. Find our full catalog of 160+ episodes on Spotify, Apple, and YouTube.TIMESTAMPED CHAPTER MARKERS0:00 - Welcome to CMO Confidential0:23 - Introducing Dave Penski, CEO of Publicis Media1:13 - State of the Business Marketplace: Volatility, Tariffs & Fragmentation4:40 - The Agency Landscape: Publicis vs. the Field5:49 - Publicis's $12B Investment Strategy & Connected Media Vision7:42 - What "Connected Identity" Actually Means (Epsilon, 255M IDs)11:35 - Agency Valuations, Margins & Who's Growing vs. Who's Cutting13:21 - The Insourcing Debate: In-House, Out-House & "Re-Housing"23:55 - AI's Real Impact on Agencies: Creative, Engineering & Media Planning30:20 - The K-Economy: Hollowing Out the Middle Class & Advertiser Confidence35:04 - The 2026 Upfront Outlook: Olympics Dollars, Midterms & What's Next40:01 - Streaming Consolidation: Paramount + Warner Bros. & the Six-Player Model42:37 - Sports as AI-Proof Content & the Fragmented Viewing Problem46:00 - Gambling: Bullish on Sports, Bearish on the Regulation Gap48:47 - CMO Advice: What to Build Now for 2027 Success50:47 - Final Advice: The Most Underrated Career Skill Is Still PunctualityTAGSCMO Confidential, Mike Linton, Dave Penski, Publicis Media, Publicis Groupe, agency business, media agency, holding company, connected identity, Epsilon, AI in marketing, AI advertising, media fragmentation, programmatic advertising, insourcing, in-house agency, agency valuations, K-economy, middle class marketing, consumer confidence, advertising marketplace, streaming consolidation, Paramount Warner Bros, sports advertising, sports media, NIL, college sports gambling, sports betting regulation, upfront market, media planning, CMO strategy, marketing leadership, CMO podcast, marketing podcast, chief marketing officer, 2027 marketing strategy, media buying, agency economics, Sapient, creative production AI, marketing AI toolsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if a simple blood test could reveal how your body responds to disease - or even help doctors choose the right treatment for you? In this episode of Rx for Biotech, host Chris Leidli speaks with Mo Jain, MD, PhD, co-founder of Sapient, about how scientists are using advanced biology and artificial intelligence to uncover new biomarkers - the biological signals that can help doctors understand what's happening inside the body. Biomarkers are becoming one of the most important tools in precision medicine, helping physicians move beyond one-size-fits-all treatments toward care that is tailored to each patient's unique biology. Mo explains how Sapient is analyzing thousands of human samples using advanced technologies to better understand metabolism, disease progression, and how patients respond to therapies. These insights could help improve early diagnosis, guide treatment decisions, and empower patients with more personalized health information. In this conversation, you'll learn: • What biomarkers are and why they matter for patients • How AI and advanced biology are helping scientists discover new health insights • Why understanding your body's metabolism can change how diseases are treated • How biomarker data could help patients and doctors make better care decisions As medicine becomes more personalized, having the right biological information may become one of the most powerful tools patients have to advocate for their own care. For additional patient education and support, visit: https://therapy4me.ai

In this episode, Saurabh Mukherjea talks to Dhruv Mehta, Chairman of Sapient. Dhruv has seen the Indian markets evolve from their infancy to the powerhouse they are today. In a conversation that ranges from deeply personal to intensely strategic, he and Saurabh strip away the complexity of finance to reveal the core principles of building a legacy.

HELLO MY HOLICS HOW THE HELL ARE YA... I LIKE TO TO THANK VK AND DAVID TO SPEND SOME TIME AND TALK ABOUT THEIR MUSIC AND ANSWER SOME NEW QUESTIONS FROM THE DOG BOWL. SO LISTEN IN AND SUBSCRIBE TO THE YOUTUBE CHANNEL AS WELL.spreaker.com/user/jtproject https://www.facebook.com/sapientscar https://www.facebook.com/JTP2014 https://www.facebook.com/DAWGPOUND2014 https://www.facebook.com/groups/allthingscoffeeBecome a supporter of this podcast: https://www.spreaker.com/podcast/jt-project--2275817/support.

En este episodio tuve la oportunidad de compartir con un gran empresario y Sapient graduado, Josué Ramírez.En esta conversación logramos entender la diligencia que cada uno debe tener en las distintas etapas de la vida, cómo entender la honra que incluyen las riquezas del reino y la mentalidad que debemos tener para crecer constantemente en cada área de nuestras vidas.

To celebrate the 10th Anniversary of HiHo Cheeseburger, restaurant powerhouse Jerry Greenberg brings a delicious burger lunch to "Naked Lunch" for his friends Phil and David and discusses how this successful tech genius -- as the co-founder and co-CEO of Sapient -- has gone on to become an important and passionate powerhouse in the restaurant world today, working successfully with various partners, creating a series of remarkable and enduringly delicious success stories starting with Sugarfish by Sushi Nozawa. Plus, some fun talk about the opening of Phil's diner, "Max & Helen's" in Larchmont! To find out more about HiHo Cheeseburger, made with 100% Grass-Fed Wagyu Beef, click here. To learn more about building community through food and "Somebody Feed the People," visit the Philanthropy page at philrosenthalworld.com.

To celebrate the 10th Anniversary of HiHo Cheeseburger, restaurant powerhouse Jerry Greenberg brings a delicious burger lunch to "Naked Lunch" for his friends Phil and David and discusses how this successful tech genius -- as the co-founder and co-CEO of Sapient -- has gone on to become an important and passionate powerhouse in the restaurant world today, working successfully with various partners, creating a series of remarkable and enduringly delicious success stories starting with Sugarfish by Sushi Nozawa. Plus, some fun talk about the opening of Phil's diner, "Max & Helen's" in Larchmont! To find out more about HiHo Cheeseburger, made with 100% Grass-Fed Wagyu Beef, click here. To learn more about building community through food and "Somebody Feed the People," visit the Philanthropy page at philrosenthalworld.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Claire chatted to Anthony Jules from Robust.AI about their AI-driven autonomous robots that work alongside humans. Anthony Jules is the CEO and co-founder of Robust.AI, a leader in AI-driven warehouse automation. The company's flagship product Carter™, is built to work with people in their existing environments, without disrupting their workflows. Anthony has a career spanning over 30 years at the intersection of robotics, AI, and business. An MIT-trained roboticist, he was part of the founding team at Sapient, held leadership roles at Activision, and has built multiple startups, bringing a unique blend of technical depth and operational scale to human-centered automation. Support Robot Talk on Patreon: https://www.patreon.com/ClaireAsher

In this  episode, host Gordon welcomes an old friend, colleague, and former boss — Jo Royce, whose remarkable career spans Glue, Sapient, Google, Unilever, and Kimberly-Clark.Together, they explore the evolution and implosion  of the creative and marketing industries in an era of AI disruption, automation, and shifting business models. They dive deep into the changing landscape of advertising and marketing, why the industry struggles to attract diverse new talent, the impact of AI on creativity and employment, leadership, learning, and staying “connected to the do” and inding purpose and humanity in fast-changing systemsAlong the way, Jo shares candid stories from her path — from building agencies to mentoring through WACL and Brixton Finishing School — and offers hope and honesty for anyone navigating change.Tune in to get refreshing insights!

Horror has always mirrored our real-world fears—and important socio-political issues. In this Halloween double feature, host The Pop Mythologist and special guest Sapient, from the blackened death metal band Abomnium, explore NIGHTBREED (1990) and A QUIET PLACE (2018) as dystopian allegories of fascism, oppression, survival, and strategic resistance. From Clive Barker's underground outcasts of Midian to John Krasinski's silent survivors, the two films reveal how horror can expose the machinery of fascism—and the courage and ingenuity it takes to survive and resist it. ⚠️ Spoiler Warning⚠️ *Spoilers for: Nightbreed (1990), A Quiet Place (2018) Lyrics for excerpt of "The Machine Awakens" by Abomnium: Broken Cratered Impact scarred Eon dust layers Hidden Photon cascade Electron displacement Sensors flicker The machine awakens [...] For the rest of the song, go find Abomnium on Bandcamp or the streaming service of your choice! Links: Abomnium on Bandcamp https://ukemrecords.bandcamp.com/album/of-time-and-dying-stars Bridge 11 on Bandcamp https://bridge11.bandcamp.com/ Sapient / Abomnium on Instagram https://www.instagram.com/abomnium/      

It's time - to rehash the event season to date and ask: where is the actual sign of innovation? Join us - and help sort out the promising HR tech from the BS, we've got special guest and HR tech analyst par excellence Stacey Harris joining Jon Reed and Brian Sommer. Harris should also have fresh data on what matters to customers and HR leaders. Brian and Jon will pick their enterprise highs and lows, with the spiffy help of Brian's infamous slide deck. Bring your savviest and snarkiest commentary, as always.... Note: if you want to see the video version with Brian's infamous slide deck, you can catch that on YouTube: https://www.youtube.com/live/FCOpVpjtbhU

It's time - to rehash the event season to date and ask: where is the actual sign of innovation? Join us - and help sort out the promising HR tech from the BS, we've got special guest and HR tech analyst par excellence Stacey Harris joining Jon Reed and Brian Sommer. Harris should also have fresh data on what matters to customers and HR leaders. Brian and Jon will pick their enterprise highs and lows, with the spiffy help of Brian's infamous slide deck. Bring your savviest and snarkiest commentary, as always.... Note: if you want to see the video version with Brian's infamous slide deck, you can catch that on YouTube: https://www.youtube.com/live/FCOpVpjtbhU

Francesco Cara, a designer, educator and curator. Francesco explores what it means to design in the current epoch, the Anthropocene, marked by climate disruption, unstoppable biodiversity loss and growing social inequality, with a focus on two domains: digital sustainability and human-wildlife coexistence. Francesco is an activist for AlGore's Climate Reality Project and for the Right to Repair. He taught ecodesign at Politecnico di Milano and IED Milano. He had various leadership roles in design at Nokia, Sapient,IconMedialab in Finland, France and the UK, and co-founded one of the earliest User-Centered Design studios in Europe, CB&J in Paris He curated Climate Space festival with Ludovico Einaudi and Ponderosa Music & Art.  Francesco has a MSc and a PhD in Cognitive Science from the University of Edinburgh.In this episode, Francesco reflects on his journey and how he went from cognitive science "in vitro" to cognition "in the wild", and design; and within design: from Human-centered design to ecodesign and human-wildlife coexistence. Francesco argues that design has a fundamental role to play in finding solutions and a new balance. He highlights the limits of ecodesign, noting that reducing social and environmental impact is not enough. He proposes a fundamental worldview shift, from considering human beings as apart from and in a position of superiority to placing human beings back within the web of life. Through several inspiring stories, he illustrates how we can create the conditions for positive relationships between people and the living world to occur. Last, he discusses his work as an activist and engaged researcher, which aims to provide more positive narratives of a future where humans live in harmony among themselves and with the living world. To learn more about Francesco's work, follow him on LinkedIn: linkedin.com/in/francescocaraand check his website: medium.com/@frakara Credits:Conception, host and production: Anne-Laure FayardSound design & Post-production: Claudio SilvaMusic & Art Work: Guilhem Tamisier

If you've been following From Lab to Launch for a while, you may remember a previous conversation with Sapient's Chief Scientific Officer, Dr. Mo Jain, a couple years back. We're thrilled to build on that conversation with Dr. Jonathan Usuka, the CEO of Sapient. Sapient is one of the largest capacity biomarker discovery labs in the world, and their mission is to accelerate drug development and improve patient outcomes through biomarker-guided therapeutics. By combining high-resolution biomolecular data with advanced computational approaches, Sapient is helping sponsors and researchers unlock new therapeutic targets and navigate complex biology at unprecedented speed and scale.With more than 25 years of experience at the intersection of business, science, and technology, Jonathan has led innovation strategies across drug development, diagnostics, and AI-driven discovery. From streamlining therapeutic pipelines to pushing the boundaries of integrated diagnostics, his work is helping reshape how biopharma organizations bring life-changing therapies to patients. Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

David's the kind of guy who can make Miracle Whip cool again—literally. A former comedian and improviser, he spent nearly 20 years leading creative teams at top ad agencies like Publicis.Sapient and VaynerMedia. Along the way, he cooked up national campaigns for iconic brands like Ferrari, Samsung Electronics, Mountain Dew Ice, and AT&T. His pièce de résistance? A Miracle Whip campaign that broke a decade-long sales slump, racked up over a billion media impressions, snagged a USA Today cover, and brought home a Cannes Lions International Festival of Creativity Silver Lion. Not bad for a guy who started out cracking jokes!

In this episode, Christina Luconi, dubbed "the original people innovator," takes host Bill Banham on a fascinating journey through her pioneering career in transforming how fast-growing companies approach their most valuable asset - their people. With refreshing candor and hard-earned wisdom, she reveals how she's helped multiple tech startups scale from dozens to thousands of employees without sacrificing their cultural foundations.The conversation explores Christina's unconventional entry into HR after studying psychology, where her willingness to question established norms ("why do we call humans 'resources'?") set her on a path of people-centered innovation. Her formative experience at Sapient during the 90s tech boom—where she helped scale from 150 to 3,500 employees in just four years—established her philosophy that culture isn't just important for growth; it's the essential foundation that makes rapid growth possible.Christina shares practical strategies from her 14-year tenure at Rapid7, where she developed the concept of "scaling with soul." Rather than imposing values from the top down, she engaged employees directly in defining the company's identity and integrated these values throughout the employee lifecycle. The approach was so successful that even terminated employees would recommend the company to others—perhaps the ultimate test of cultural strength. She eloquently articulates how diversity of thought and cultural alignment can coexist when organizations focus on shared values while encouraging authentic self-expression.Now launching her consulting practice, People Innovations, Christina aims to help early-stage companies recognize the critical importance of human-centered approaches from day one. Having faced personal health challenges that shifted her perspective, she's passionate about maximizing her impact across multiple organizations. Despite acknowledging the current difficulties in people leadership, she remains optimistic: "This could be one of the most pivotal and important roles in a company because ultimately, it doesn't matter what you're building or selling...AI might replace a lot of stuff, but it can't replace human relationships and trust and collaboration."Ready to transform how your organization approaches culture and growth? Subscribe to the HRchat Show for more insights from visionary leaders who are redefining the world of work.Support the showFeature Your Brand on the HRchat PodcastThe HRchat show has had 100,000s of downloads and is frequently listed as one of the most popular global podcasts for HR pros, Talent execs and leaders. It is ranked in the top ten in the world based on traffic, social media followers, domain authority & freshness. The podcast is also ranked as the Best Canadian HR Podcast by FeedSpot and one of the top 10% most popular shows by Listen Score. Want to share the story of how your business is helping to shape the world of work? We offer sponsored episodes, audio adverts, email campaigns, and a host of other options. Check out packages here. Follow us on LinkedIn Subscribe to our newsletter Check out our in-person events

For years, disease diagnosis and treatment have focused on a few biomarkers, overlooking thousands of vital biological signals. Despite biotech advances, most therapies are still based on limited data, missing countless breakthroughs.Multiomics changes that. By analyzing tens of thousands of proteins, metabolites, and lipids, it reveals hidden insights, paving the way for smarter, faster, and more effective medical discoveries.In this must-listen episode, David Brühlmann welcomes Mo Jain, founder and CSO of Sapient, a pioneering force in bringing multiomic platforms out of academia and into the heart of drug development. A physician-scientist by training and a visionary entrepreneur by choice, Mo's journey spans decades at the cutting edge of analytical technologies, culminating in the creation of ultra-high-throughput systems that analyze up to 20,000 biomarkers in a single run for real-world impact.Here are three reasons why this episode needs to be on your playlist:Multiomics at Scale: Mo shares how his team at Sapient turbocharged mass spectrometry, enabling simultaneous measurement of thousands of molecules, transforming routine diagnostics and making previously unimaginable insights accessible to scientists everywhere.Turning Data into Action: Generating vast data is only half the battle. Mo explains how Sapient developed advanced biocomputational teams and frameworks to extract actionable answers, guiding drug developers to faster, smarter decisions and helping avoid the pitfalls that cripple so many omics projects.The Future Is Personalized and Sooner Than You Think: From dramatically earlier disease detection to truly personalized therapies, Mo paints an optimistic picture of a coming era where AI, multiomics, and new therapeutic modalities rapidly accelerate both discovery and delivery, reshaping how biotech companies tackle even the toughest diseases.Ready to break out of the 20-biomarker rut and see what 20,000 data points can reveal? Tune in to discover how you can harness multiomics in your own research and hear Mo's advice for scientists and entrepreneurs venturing beyond the bench.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

What if the secret to truly personalized precision medicine lies not in your genetic code, but in your zip code?For years, biotech has focused on genomics to explain disease and drug response, but DNA only accounts for a fraction of the story. The real breakthrough? Multi-omics: the large-scale analysis of proteins, metabolites, and lipids, powered by advanced mass spectrometry and AI, offering a fuller picture of human health.In this episode, David Brühlmann meets Mo Jain, founder and CSO of Sapient, a leader in multi-omics analytics. With over two decades of experience across physiology, biomedicine, and computational biology, Mo has been at the forefront of developing scalable multi-omics technologies that are changing the way we predict, diagnose, and treat disease. From leading an academic lab to building a pioneering biotech company, Mo's journey reflects a passion for uncovering the hidden 80–90% of disease risk that lies beyond our genes.Here are three reasons you'll want to listen to this episode:Your Environment Matters More Than Your Genes: Mo explains why your zip code is a stronger predictor of your health than your genetic code, challenging the industry's long-held beliefs and opening new avenues for disease prevention and risk assessment.Multi-omics Disrupts Drug Development: Discover how integrating thousands of biological data points can revolutionize drug discovery by identifying novel targets, better predicting drug response, and accelerating therapeutic breakthroughs that were previously out of reach.Big Data Finally Becomes Actionable: Thanks to rapid advances in mass spectrometry and computational power, scientists can now make sense of overwhelming volumes of multi-omic data, turning what was once information overload into actionable insights for diagnostics and drug development.Ready to think beyond your genes? The biotech revolution is here, and it starts in your neighborhood.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

The job market may be sending mixed signals, but one thing's clear—companies still hire problem-solvers. In this episode, Jill talks with Kristian Schwartz, founder of The Montgomery Group, about navigating today's complex hiring landscape with clarity, confidence, and strategy.Kristian shares how AI is changing the game, how to use summer wisely, and what top candidates are doing differently right now.Why AI fluency is no longer optional—only 10% are using it wellHow to turn the summer slowdown into a strategic advantageWhat “builder-leaders” are—and why companies want themThe right way to follow up after interviews (and when to walk away)Show Guest: Kristian Schwartz founded The Montgomery Group, a boutique search firm specializing in senior-level marketing and media placements. Kristian is a seasoned strategic leader with deep experience on both the agency and client side, having worked at Wired Magazine, Razorfish, and Sapient, and partnered with brands like Visa, Verizon, Clorox, Unilever, and HP. Show Notes:Ready to lead with clarity, confidence, and impact?Take the Make Your Power Move Leadership Assessment and unlock the tools to define your leadership identity, elevate your influence, and step into your next role with purpose. For a limited time, use code POWER to get 50% off. → Start your Power Move today.  Learn More HERESupport the showJill Griffin, host of The Career Refresh, delivers expert guidance on workplace challenges and career transitions. Jill leverages her experience working for the world's top brands like Coca-Cola, Microsoft, Hilton Hotels, and Martha Stewart to address leadership, burnout, team dynamics, and the 4Ps (perfectionism, people-pleasing, procrastination, and personalities). Visit JillGriffinCoaching.com for more details on: Book a 1:1 Career Strategy and Executive Coaching HERE Build a Leadership Identity That Earns Trust and Delivers Results. Gallup CliftonStrengths Corporate Workshops to build a strengths-based culture Team Dynamics training to increase retention, communication, goal setting, and effective decision-making Keynote Speaking Grab a personal Resume Refresh with Jill Griffin HERE Follow @JillGriffinOffical on Instagram for daily inspiration Connect with and follow Jill on LinkedIn

In this episode, Amir sits down with Anthony Jules, Co-Founder and CEO of Robust.AI, to explore how scaling lessons from the early days of Sapient translate into today's rapidly evolving world of AI and robotics. Anthony shares stories from growing a company from 3 to 4,000 people, what scale teaches you about communication and change, and how being ruthlessly honest about your business creates strategic advantage. From the hype vs. reality of AI to how hardware can stabilize innovation in robotics, this conversation is rich with insights for technologists, entrepreneurs, and leaders navigating change.

Send us a textIn this episode of the Life Science Success Podcast my guest is Jonathan Usuka, a seasoned pharmaceutical industry executive with over 25 years of experience in both scientific and business leadership roles. Dr. Usuka brings a wealth of knowledge from his diverse background, including senior positions at top pharmaceutical companies, strategic roles at McKinsey & Company, and his current role as CEO at Sapient.00:00 Introduction to Life Science Success Podcast00:34 Guest Introduction: Jonathan Usuka00:52 Jonathan's Journey into Pharmaceuticals03:23 Advancements in Genomics and Personalized Medicine05:29 Key Milestones in Jonathan's Career09:07 Challenges and Team Management11:37 Current Role and Mission at Sapient16:21 Innovative Projects and AI Integration29:02 Leadership Insights and Career Advice34:30 Concerns and Future of AI41:37 Closing Thoughts and Podcast Wrap-Up

Dr. Jonathan Usuka, CEO of Sapient, uses insights about proteomics and metabolomics to provide deep molecular characterization of diseases from a single sample to support drug discovery, development, and approval. The company's unique dataset combines real-world data with longitudinal molecular profiling of tens of thousands of samples across different diseases, ethnicities, genders, and ages.  By measuring proteins and metabolites, this data and insights engine helps pharmaceutical companies gain a significantly more comprehensive view of the molecular basis of disease, better understand drug targets, and predict potential drug outcomes and safety. Jonathan explains, "We support drug discovery and drug development, and a couple of things are going on in the industry right now in discovery and development. One is the overall pharma landscape of how a drug gets approved. That's been fairly static since the 1970s with the creation of the FDA. So clinical trials are well established, but the structure of it was based around not knowing much about the underlying drug target that your drug is interacting with. Since then, they've tightened up the requirements around mechanisms of action, but mostly, the process itself is almost protein agnostic in terms of the development process and how the drug interacts with patients." "So what we do, what has happened recently, is a revolution in understanding the molecular basis of disease and how the therapeutics interact with it at a molecular level. We support pharmaceutical companies in understanding the safety and the efficacy and being able to predict how their therapies will do in the clinic, and then really understanding a lot more about the available drug targets, which expands the arsenal of ways to fight disease."    "At Sapient, we don't just identify dynamic biomarkers, biomarkers that change with disease or change in response to therapy. We also give a lot of context about those biomarkers. We also say where we have seen those biomarkers occur and how they have changed in response to other therapies, disease conditions, and immunological responses. So, a pharma company can see better what it's getting into when it invests in a dynamic biomarker."  #SapientBio #Multiomics #Proteomics #Metabotomics #DarkProteome #BeyondtheGenome #Plasmaproteomics #Biomarkers  sapient.bio Download the transcript here

Dr. Jonathan Usuka, CEO of Sapient, uses insights about proteomics and metabolomics to provide deep molecular characterization of diseases from a single sample to support drug discovery, development, and approval. The company's unique dataset combines real-world data with longitudinal molecular profiling of tens of thousands of samples across different diseases, ethnicities, genders, and ages.  By measuring proteins and metabolites, this data and insights engine helps pharmaceutical companies gain a significantly more comprehensive view of the molecular basis of disease, better understand drug targets, and predict potential drug outcomes and safety. Jonathan explains, "We support drug discovery and drug development, and a couple of things are going on in the industry right now in discovery and development. One is the overall pharma landscape of how a drug gets approved. That's been fairly static since the 1970s with the creation of the FDA. So clinical trials are well established, but the structure of it was based around not knowing much about the underlying drug target that your drug is interacting with. Since then, they've tightened up the requirements around mechanisms of action, but mostly, the process itself is almost protein agnostic in terms of the development process and how the drug interacts with patients." "So what we do, what has happened recently, is a revolution in understanding the molecular basis of disease and how the therapeutics interact with it at a molecular level. We support pharmaceutical companies in understanding the safety and the efficacy and being able to predict how their therapies will do in the clinic, and then really understanding a lot more about the available drug targets, which expands the arsenal of ways to fight disease."    "At Sapient, we don't just identify dynamic biomarkers, biomarkers that change with disease or change in response to therapy. We also give a lot of context about those biomarkers. We also say where we have seen those biomarkers occur and how they have changed in response to other therapies, disease conditions, and immunological responses. So, a pharma company can see better what it's getting into when it invests in a dynamic biomarker."  #SapientBio #Multiomics #Proteomics #Metabotomics #DarkProteome #BeyondtheGenome #Plasmaproteomics #Biomarkers  sapient.bio Listen to the podcast here

In this episode of the Data and Biotech Podcast, host Ross Katz sits down with Dr. Jonathan Usuka to discuss Usuka's extensive background in bioinformatics and genomics, leading to his current role as CEO of Sapient.  The conversation dives into the importance of deep molecular characterization of diseases, the role of proteomics and metabolomics in drug discovery, and the gaps between real-world data and clinical trial data.  As a leader with a small but impactful team, Jonathan discusses the complexities of the dark proteome and metabolites, emphasizing the opportunity for deeper biological insights in pharmaceutical research using repeated, deep profiling of the same cohorts of patients. Jonathan also explores how advancements in computational approaches allow Sapient to build a robust data foundation for insight generation in biopharma.  ​​What You'll Learn in This Episode: The significance of longitudinal patient samplingWhy we need robust conclusions in biotechnology How the role of the FDA is evolving for drug approval and personalized medicine applications Connect with Our Guest: Sponsor: CorrDyn, a data consultancyFind out more about Sapient Connect with Dr. Jonathan Usuka on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!

MPF Discussion with Tomi (TD) DaviesBridging the Gap: Angel Investing in Africa with Tomi (TD) Davies About Tomi (TD) DaviesTomi Davies (TD) is the Collaborator-in-Chief at TVC Labs, a technology innovation hub in Lagos, Nigeria. He co-founded Zeitec, the Lagos Angel Network (LAN), and serves as the founding President of the African Business Angel Network (ABAN) and board member of the Global Business Angel Network (GBAN).With a degree from the University of Miami, TD led tech transformation projects for global brands like Marks & Spencer, Ernst & Young, and Sapient. Since 2000, he has focused on tech-driven innovation across Africa, publishing The African Project Manager in 2014. Named one of the “100 Most Influential Africans of 2021” by New African Magazine, TD also serves as Chairman of Powerstove and holds board roles with Trove, Omnibiz, and Big Cabal Media.He chairs the Innovation Committee of the Lagos State Science, Research, and Innovation Council (LASRIC).Bridging the Gap: Angel Investing in AfricaWhat does it take to unlock the potential of Africa's startup scene? In this episode, we chat with TD (Tomi Davies), a trailblazer in angel investing and tech innovation. TD's career journey is nothing short of extraordinary—from shaping cutting-edge projects in the 1990s to co-founding a network that connects investors across the continent.TD introduces his POEM Framework, a practical tool for evaluating startups, and shares how a failed investment helped shape his approach to success. Discover why Africa's startup ecosystem is thriving and how startups can drive meaningful social impact.What You'll Learn:•TD's path from corporate success to angel investing.•The pivotal moment that led to his first investment.•How the POEM Framework helps startups achieve sustainable growth.•Challenges and triumphs of connecting angel investors in Africa.•Why real-world impact is the future of innovation.Links to Tomi•Tomi's website: https://tomidavies.com/•Order: Investment Worthy Startup: https://www.amazon.com/Investment-Worthy-Startup-building-investors/dp/B0BV4JCSG1?source=ps-sl-shoppingads-lpcontext&ref_ •Order: https: The African Project Manager -  https://www.amazon.com/African-Project-Manager-Managing-Successfully/dp/1494285347 •Subscribe to Tomi's YouTube: https://www.youtube.com/channel/UCo5rUX9cw9N4KjQLoKLqtKg Please Leave A ReviewLike this show? Please leave us a review here, even one sentence helps! Consider including your Twitter handle so we can thank you personally!Paul: Contact DetailsWork with me: paul@myperfectfailure.comMPF Website: https://www.myperfectfailure.com/ Subscribe to MPF YouTube channel:  https://www.youtube.com/@paulpadmore8275

“The OOOps methodology from the science of happy accidents are optionality, opportunism, and optimization.” Stephen Fishman and Matt McLarty are the authors of “Unbundling the Enterprise: APIs, Optionality, and the Science of Happy Accidents”, a book from IT Revolution. In this episode, we discuss the transformative power of APIs, the importance of optionality in technology and business, and the intriguing science of ‘happy accidents'. We delve into the “OOOps” of the science of happy accidents, which are optionality through API unbundling, opportunism through value dynamics, and optimization through feedback loops. Stephen and Matt share real-world examples of how companies like Amazon, Google, and Cox Automotive have successfully unbundled their enterprises and leveraged optionality for growth and innovation. Also, hear the story and impact of Jeff Bezos's legendary API mandate at Amazon, which revolutionized Amazon to become the giant it is now. Towards the end, we discuss the role of AI in the future of work and how we can use AI along with APIs to embrace more optionality and create more business value. Listen to the full episode to learn more about how you can apply these concepts to your digital transformation journey and benefit from the power of APIs and optionality.   Listen out for: Career Turning Points - [00:01:51] “Unbundling the Enterprise” Book - [00:05:21] Amazon API Revolution - [00:08:39] What Drove Jeff Bezos's Mandate - [00:14:10] Optionality Through API Unbundling - [00:17:36] Happy Accidents - [00:23:59] Opportunism Through Value Dynamics - [00:26:59] Value Dynamics - [00:30:55] Optimization Through Feedback Loops - [00:38:03] Embracing AI - [00:45:24] 4 Tech Lead Wisdom - [00:52:02] _____ Stephen Fishman's BioStephen Fishman (Fish) is the NA Field CTO for Boomi. He is a practicing technologist who brings creativity, rigor, and a human-centric lens to problem-solving. Known as an expert in aligning technology and business strategy, Stephen places a premium on pushing business and technology leaders to embrace iteration and the critical need to collaborate across disciplines. In addition to consulting with large organizations, Stephen is an in-demand speaker and advisor. Stephen has led multidisciplinary teams to deliver amazing results at Salesforce, MuleSoft, Cox Automotive, Sapient, Macy's, and multiple public sector institutions including the US Federal Reserve and the CDC. Matt McLarty's BioMatt McLarty is the Chief Technology Officer for Boomi. He works with organizations around the world to help them digitally transform using a composable approach. He is an active member of the global API community, has led global technical teams at Salesforce, IBM, and CA Technologies, and started his career in financial technology. Matt is an internationally known expert on APIs, microservices, and integration. He is co-author of the O'Reilly books Microservice Architecture and Securing Microservice APIs, and co-host of the API Experience podcast. Follow Stephen: LinkedIn – linkedin.com/in/stephenhfishman Email – stephen.fishman@boomi.com Follow Matt: LinkedIn – linkedin.com/in/mattmclartybc Email – matt.mclarty@boomi.com Book & Podcast:

This week on Data in Biotech, we're joined by Mo Jain, the Founder and CEO of Sapient, a biomarker discovery organization that enables biopharma sponsors to go beyond the genome to accelerate precision drug development.  Mo talks us through his personal journey into the world of science, from school to working in academia to founding his business, Sapient. He explains how and why Sapient first started and the evolution of the high-throughput mass-spectrometry service it provides to the biopharmaceutical sector.  Together with our host Ross, they explore the technology that's allowed scientists to explore one's medical history like never before via metabolome, lipidome, and proteome analysis. They look at how the technology developed to allow data testing to go from running twenty tests per blood sample to twenty thousand. How have Sapient built themselves up to such a renowned status in biopharmaceuticals for large-scale data projects? They discuss Sapient's process when working with clients on genome projects. We learn about Sapient's relationship with their clients, how they understand the targets and aims of each project, why they put so much importance on proprietary database management and quality control, and Sapient's three pillars for high quality data discovery. Finally, Mo takes the opportunity to give us his insights on the future of biomarker discovery and mass-spectrometry technology - and how AI and Machine Learning are leading to enhanced data quality and quantity.  Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in the life sciences. Chapter Markers [1:33] Introduction to Mo Jain, his journey, Genomics, and Sapient's use of Genomics data to accelerate Medicine and Drug Development  [6:50] The types of data generated at Sapient via metabolome, lipidome & proteome, and why that data is generated [12:30] How Sapient generates this data at scale, via specialist mass-spectrometry technology  [14:48] The problems Sapient can solve for pharma and biotech companies with this data [21:03] Sapient as a service company: the questions they're asked by pharmaceutical businesses, why they come to Sapient, and Sapient's process for answering those questions.  [26:23] computational frameworks and data handling side of things, and how the team interact with the client [29:59] Proprietary database development and quality control  [35:27] The future of biomarker discovery and mass-spectrometry technology, and how AI and Machine Learning are leading the way at Sapient

Malcolm joined Cheil Worldwide at the beginning of 2015 as the Network's first ever Global Chief Creative Officer. Having built and led teams responsible for award-winning firsts as diverse as Foot Locker's Sneakerpedia, Dove's Campaign For Real Beauty and Samsung's #BeFearless VR experience, Malcolm is a recognised industry influencer and speaker. A two time Cannes Lions Jury President, Clio Awards and LIA Awards Jury president, Malcolm was recently named one of AdAge magazine's “World's Top 10 Digital minds” and named by TechCity Insider as one of the UK's leading Digital Innovators. His international industry accolades number more than 500, including Cannes Lions for Film, Print, Media, Outdoor, Cyber, Glass and Mobile. Prior to joining Cheil, Malcolm was European Chief Creative Officer and a member of Sapient's global leadership team where he helped build the company to in excess of a billion dollars in annual revenue, putting Sapient amongst Fortune Magazine's 40 fastest growing companies in the world. M&CSaatchi, Saatchi&Saatchi, Ogilvy and SapientNitro have all won Agency of the Year titles during his creative leadership. With Cheil Worldwide, Malcolm has steered the network into the industry's Top 10 Creative Network rankings and has seen the Network win their first Glass Lion at Cannes, first Innovation award at AdFest, Gran Sol at El Sol Awards, Grand Prix at Dubai Lynx, Gold at the International ANDY awards, collect their first WEBBY awards, create the Most Viewed Ad in the World on YouTube and post record new business success with Samsung along with winning global accounts including Etihad Airways, adidas, PZ Cussons, Abbot and UN Women. A Kiwi, Malcolm is a former member of the NZ Yachting Team, recognised by KEA as a ‘World Class New Zealander', former board member of the UK's Institute of Contemporary Art, Patron of the Royal Academy of Arts, C.A.L.M. and a member of the Academy of Digital Arts and Sciences. Malcolm lives in London with his Australian wife and English daughter.

Malcolm joined Cheil Worldwide at the beginning of 2015 as the Network's first ever Global Chief Creative Officer. Having built and led teams responsible for award-winning firsts as diverse as Foot Locker's Sneakerpedia, Dove's Campaign For Real Beauty and Samsung's #BeFearless VR experience, Malcolm is a recognised industry influencer and speaker. A two time Cannes Lions Jury President, Clio Awards and LIA Awards Jury president, Malcolm was recently named one of AdAge magazine's "World's Top 10 Digital minds" and named by TechCity Insider as one of the UK's leading Digital Innovators. His international industry accolades number more than 500, including Cannes Lions for Film, Print, Media, Outdoor, Cyber, Glass and Mobile. Prior to joining Cheil, Malcolm was European Chief Creative Officer and a member of Sapient's global leadership team where he helped build the company to in excess of a billion dollars in annual revenue, putting Sapient amongst Fortune Magazine's 40 fastest growing companies in the world. M&CSaatchi, Saatchi&Saatchi, Ogilvy and SapientNitro have all won Agency of the Year titles during his creative leadership. With Cheil Worldwide, Malcolm has steered the network into the industry's Top 10 Creative Network rankings and has seen the Network win their first Glass Lion at Cannes, first Innovation award at AdFest, Gran Sol at El Sol Awards, Grand Prix at Dubai Lynx, Gold at the International ANDY awards, collect their first WEBBY awards, create the Most Viewed Ad in the World on YouTube and post record new business success with Samsung along with winning global accounts including Etihad Airways, adidas, PZ Cussons, Abbot and UN Women. A Kiwi, Malcolm is a former member of the NZ Yachting Team, recognised by KEA as a ‘World Class New Zealander', former board member of the UK's Institute of Contemporary Art, Patron of the Royal Academy of Arts, C.A.L.M. and a member of the Academy of Digital Arts and Sciences. Malcolm lives in London with his Australian wife and English daughter.

Sustainable growth hinges on leadership tactics that delegate authority and responsibility.  Adam Sandman's journey of  bootstrapping, diversifying markets, and building a strong global team, demonstrated that smart, intentional decisions are what drive long-term success. His approach to leadership—decentralized, customer-focused, and growth-oriented—is what empowers teams to innovate and adapt, ensuring the company remains resilient and competitive in a global marketplace.About Adam SandmanAdam Sandman is the founder and CEO of Inflectra, a company that creates tools for software testing and automation. His journey with programming started when he was just ten, making computer games for fun. Later, he studied Physics at Oxford University but realized that working in labs wasn't for him. So, he moved to the U.S. to follow his passion for technology.One of Adam's first big roles was at Sapient, where he worked on projects for the U.S. Marine Corps. Eventually, he decided to start his own company, and that's how Inflectra came to be. What began as a small business grew into a leader in the software industry. Adam's focus has always been on creating innovative products and expanding the business. Today, Inflectra is known around the world for its top-notch software management tools.Key Insights:Start small, stay in control. Build your business without relying on outside funding so you can make decisions that align with your long-term goals. This way, you maintain control over your company's direction and can grow at your own pace.Mix up your client base. Diversify your client portfolio by balancing startups with more established companies to provide stability and reduces the risk of losing significant revenue during market downturns.Build strong partnerships. Develop relationships with partners who can help you reach new customers and expand your business. These partnerships can act as a force multiplier, amplifying your sales and marketing efforts.Define your sales process. Before hiring salespeople, map out your sales process and understand the specific roles needed. Make sure you hire the right people for the right tasks and avoid costly mistakes.Focus on customer needs. Prioritize building products and services that truly meet your customers' needs, even if it goes against industry trends. A customer-focused approach builds loyalty and drives long-term success.Adam's best advice for entrepreneurs:“You need to define your sales process differently before you start hiring people because otherwise what you'll do is you hire people like you or you hire people who are call themselves salespeople, but that may or may not be what you need in your particular moment in that particular phase.”Connect with Adam Sandman:LinkedInXInstagramFollow Beyond 8 Figures:LinkedInXWebsite

Barry and Phil are thrilled to be joined by Donald Chesnut, a CX, Product Design and Customer Success Leader and the former CXO of General Motors, Mastercard, and Sapient. In this episode, Donald regales us with a brief history lesson of how the field of UX evolved from the early days of AOL to the present day of Product and CX, and what we can expect for the future of the field. We discuss the ethical dilemmas posed by data-rich, AI-driven experiences, and the role Designers must play in preserving intent, perception, and understanding for the user. We also discuss Donald's upcoming book, and how the lessons learned from the past are informing our shared future. Whether you are a seasoned design and UX pro, a junior designer just starting out, or a business leader trying to understand where the market is going, this is the episode you should listen to. Cheers! --- Send in a voice message: https://podcasters.spotify.com/pod/show/whatbubblesup/message Support this podcast: https://podcasters.spotify.com/pod/show/whatbubblesup/support

Kristian Schwartz spearheads The Montgomery Group, a boutique search firm he established, specializing in senior-level marketing and media placements. He is known throughout the industry for his thank-you notes. In this episode, we explored the power of thank-you notes and their impact on your professional brand. Whether digital or handwritten, thank-you notes create lasting impressions and show genuine appreciation. In this episode we discussThe benefits of sending thank you notes.What happened when a top company didn't receive any thank you notes from their leading candidatesShould they be digital or handwritten?How do different generations feel about thank-you notes?How thank you notes contribute to your professional brandShow guest:Kristian Schwartz, a seasoned leader with over 20 years in digital transformation and marketing, transitioned to executive search at Korn Ferry, rising to Senior Partner. His professional journey is a testament to his expertise, with tenure at renowned companies such as Wired Magazine, Razorfish, and Sapient, where he collaborated with influential Fortune 500 brands like Visa, Verizon, Clorox, Unilever, and Hewlett-Packard. Kristian founded  The Montgomery Group, a boutique search firm., specializing in senior marketing and media placements. He holds a B.S. in Microeconomics from the University of Oregon. Support the Show.Jill Griffin helps leaders and teams thrive in today's complex workplace. Leveraging her extensive experience to drive multi-million-dollar revenues for brands like Coca-Cola, Microsoft, Samsung, and Hilton Hotels, Jill applies a strategic lens to workplace performance, skillfully blending strategy and mindset to enhance productivity, teamwork, and career satisfaction across diverse organizations. Visit JillGriffinCoaching.com for more details on: Book a 1:1 Career Strategy and Executive Coaching HERE Gallup CliftonStrengths Corporate Workshops to build a strengths-based culture Team Dynamics training to increase retention, communication, goal setting, and effective decision-making Keynote Speaking Grab a personal Resume Refresh with Jill Griffin HERE Follow @JillGriffinOffical on Instagram for daily inspiration Connect with and follow Jill on LinkedIn

Jack Skeels is a former RAND senior analyst and agency executive. He is the CEO of AgencyAgile, an operations consulting and coaching firm that has helped over 200 agencies, consultancies, and other project-driven organizations go better, faster, and happier.  Jack's new book, Unmanaged: Master the Magic of Creating Empowered and Happy Organizations, is available on Amazon.His career includes leading Sapient's 105-person Los Angeles office, and founding and executive roles in multiple startups.  He is a coach to executives, a thought leader and evangelist to industry, and wakes every day driven to create a revolution in leadership and management practices, optimal organization design, and delivery excellence.  Jack is recognized as an outstanding speaker, writer, and educator.  He speaks at over 15 industry and association events per year, including Ad Age, Digiday, SoDA (annual meeting and The SoDA Academy), 4A's conferences, Advertising Week, Magnet Global, Miss Collective, TAAN, Bureau of Digital, and others.  With over 35 published articles, his work frequently appears in leading publications such as: Ad Age, Entrepreneur.com, Ad Week, MediaPost, and Campaign.us.Jack is a two-time Inc-500 Award winner and entrepreneur, with several successful startups to his credit.  In addition to a bachelor's in Industrial Engineering and an MBA with honors in Entrepreneurship and Finance from the Marshall School of Business, he has held several graduate-level teaching roles, including associate professor at the RAND-Pardee School of Public Policy.Find Jack on LinkedIn at: https://www.linkedin.com/in/jackaskeels/ ----- John Bates provides 1:1 Executive Communications Coaching, both in-person and online, as well as large and small group training. Sign up for his free weekly micro-trainings at https://johnbates.com/mini-trainings and create a great leadership communications habit that makes you the kind of leader who inspires trust, loyalty and connection.

On episode 388 of the BlockHash Podcast, CEO Adam Sandman joins Brandon Zemp to talk about Inflectra, a market leader in software test management, test automation, application lifecycle management, and the enterprise portfolio management space. Adam Sandman founded Inflectra in 2006. Today, Adam serves as the company's CEO. He is responsible for product strategy, technology innovation, and business development. He lives in Washington, D.C., with his family. Prior to founding Inflectra, Sandman worked as a director for Sapient Government Services, where he was in charge of development with the U.S. Marine Corps. and other government agencies, and was responsible for leading many capture teams and writing whitepapers and position statements to build Sapient's reputation as a leader in the defense space. He studied physics at Oxford University. ⏳ Timestamps: 0:00 | Introduction 1:42 | Who is Adam Sandman? 5:31 | What is Inflectra? 6:38 | What type of clients does Inflectra work with? 7:50 | Inflectra product suite 8:49 | Inflectra Use-cases 16:10 | How A.I. changes the software industry 22:16 | Will we see Regulations for A.I. in the United States? 22:56 | Generative A.I. at Inflectra 28:33 | Risks of A.I. in Software 32:15 | Inflectra's 2024 Roadmap 34:14 | Where to learn more about Inflectra

Rishi Singh, founder and CEO at Sapient.ai, speaks with SE radio's Kanchan Shringi about using generative AI to help developers automate test code generation. They start by identifying key problems that developers are looking for in an automated test-generation solution. The discussion explores the capabilities and limitations of today's large language models in achieving that goal, and then delves into how Sapient.ai has built wrappers around LLMs in an effort to improve the quality of the generated tests. Rishi also suggests how to validate the generated tests and outlines his vision of the future for this rapidly evolving area. Brought to you by IEEE Computer Society and IEEE Software magazine. This episode is sponsored by WorkOS.

Believe it or not, there once was a time when the hottest show in town was a pig doing maths. A porcine professor might not sound as binge-worthy as The Traitors or a double bill of Miss Marple, but back in 1817 people flocked to see this canny swine. James presents the story of a learnéd pig named Toby, as told in his own words. (The pig's own words, that is.) This episode started life as our Xmas Pig 2023 Livestream, which you can watch in full with all the trimmings here. LoreBoys nether say die! Support the Loremen here (and get stuff): patreon.com/loremenpod ko-fi.com/loremen Check the sweet, sweet merch here... https://www.teepublic.com/stores/loremen-podcast?ref_id=24631 @loremenpod youtube.com/loremenpodcast www.instagram.com/loremenpod www.facebook.com/loremenpod

According to Harris, the most important question for 2024 is “Do we have the data?” Hear about Sapient Insight Group's newest research and why Harris believes transformational leave management is a key HR priority this coming year. “Don't just do change management,” she says, “manage the change. Employees are burning out. Give your executives a reality check.”Unum took its Gartner Marketing Award-winning HR Trends podcast studio on the road (again) to the 2023 HR Technology Conference & Exposition, held October 10–13 in Las Vegas. Listen as HR Trends host Clare Morin and others interview some of the biggest influencers in the HR tech world. You'll hear their expert opinions on how technology will change the HR profession and improve the employee experience through 2024 and beyond. 

Episode Video + Transcript Tom Morgan is known as the 'most interesting man in finance' and Director at Sapient Capital!  His widely acclaimed weekly newsletter has captured the attention of Wall Street's finest minds. Tom, who describes his role as a "curiosity sherpa for billionaires," shares his insights on the transformative power of curiosity in personal and professional spheres and how to follow your bliss in a data-driven world. On this episode we explore - why the real superpower is living a life where what's blissful for you and beneficial for the world gradually becomes the same thing. How your most painful moments in life can lead to your greatest insights.  And why Tom thinks when of the biggest problems we face is not having a space for people in mid-life to make successful transitions to the next stage of life. My new book, Masterpiece in Progress: A Daily Guide to a Life Well Crafted, is out now! Order HERE Find out more – MasterPieceInProgressBook.com Inside the pages of Masterpiece in Progress, you'll find 365 motivational passages, one for each day of the year, carefully designed to challenge, inspire, and create personal and professional evolution in your life. But that's not all! In Masterpiece in Progress, readers will find: 365 motivational passages: Daily insights to challenge, inspire, and instigate personal and professional evolution. Timeless wisdom: Life lessons that serve as the foundational stones for a future sculpted by dreams, authenticity, and unwavering passion. Practical tools & insights: A treasure trove of strategies tailored to awaken the dormant potential that rests within every individual. Masterpiece in Progress is more than a book; it's your daily companion in the art of living magnificently. Are you ready to begin crafting your masterpiece? The journey starts now. I've poured everything I have into this book, with the aim of making it your go-to resource in the art of living a magnificent life. Checkout what people are saying about the book: “Intensely positive and upbeat, Sean DeLaney crafts a master class in personal development. This book is about the art of AMPing up your life.” – Frank Slootman, CEO, Snowflake and author of Amp It Up “Operating in some of the world's most challenging environments, I've seen firsthand the importance of grit, resilience, and relentless pursuit of excellence. Masterpiece in Progress embodies these principles, offering a roadmap to all who aim to conquer their personal and professional battles.”— Michael Burns, US Navy SEAL (Retired), Bronze Star Medal with Valor “Sean's beautiful, thoughtful writing reminds you what's important and calls your attention to a perspective that lifts your spirit each day. Highly recommended.” – Derek Sivers, author, sive.rs Subscribe to my Momentum Monday Newsletter Connect with us! Whatgotyouthere TikTok YouTube Twitter Instagram 

On this episode of Let's Be Blunt, Montel speaks with Steven Hoffman. Mr Hoffman served as the initial Chairman of the Massachusetts Cannabis Control Commission from 2017 – 2022 where he was responsible for standing up a safe and equitable market for recreational cannabis in the state and expanding access to the medical cannabis program. Prior to serving on the Commission, he was a Senior Partner at Bain & Company, the Chief Strategy Officer for Sapient and the CEO of two venture capital backed technology start-ups. He currently serves on the Board of Directors and Advisory Boards of several cannabis businesses with a focus on bringing clinical support and higher quality products to medical cannabis patients.

Ray and Ariel discuss the different categories of sentient magic items that appear in popular fiction and Dungeons and Dragons. From Nightblood to the One Ring, we deconstruct their sentience so that you can use the pieces to build your own items at your own tables. Website: https://runningofftherails.com Emery's Log of Legendary Eminences: https://www.kickstarter.com/projects/runningofftherails/emerys-log-of-legendary-eminences⁠ Instagram: https://www.instagram.com/runningofftherails Twitter: https://twitter.com/RunningOffRails

Kristian Schwartz spearheads The Montgomery Group, a boutique search firm he established, specializing in senior-level marketing and media placements. Kristian is a seasoned strategic leader renowned for elevating premier brands through a blend of strategic hiring and consulting expertise. He has extensive experience working on various facets of the industry, and his professional journey includes tenure at renowned companies such as Wired Magazine, Razorfish, and Sapient, where he collaborated with influential Fortune 500 brands like Visa, Verizon, Clorox, Unilever, and Hewlett-Packard. In this episode, we discuss: Best Practices for Effective Collaboration with Executive Search PartnersThe Importance of Nurturing RelationshipsHow to find RecruitersKey Elements Sought by Recruiters in ResumesThe Crucial Role of Career StrategyAdapting Resume Requirements for Recruiters versus Applicant Tracking Systems (ATS)Mentioned on the show  Forbes List of America's Top Recruiting FirmsGet a copy of Kristian Schwartz's Win a Day HEREShow guest: Kristian Schwartz is a seasoned leader with over two decades of experience driving digital transformation and marketing initiatives. Recognizing his knack for spotting transformative talent, Kristian transitioned into executive search at Korn Ferry, rising to Senior Partner in the Integrated and Digital Marketing practice. Presently, he leads The Montgomery Group, a boutique search firm he founded, which specializes in senior-level marketing and media placements. Holding a Bachelor of Science in Microeconomics from the University of Oregon, Kristian, a dedicated father to twin daughters, enjoys activities such as cycling, cooking, and fly fishing.Follow Kristian Schwartz on LinkedIn Support the showJill Griffin is dedicated to enhancing workplace life by guiding leaders in shaping their next chapter, elevating their well-being, intentionality, and overall impact. Jill's executive coaching, strategy, workshop facilitation, and innovation have generated multi-millions in revenue for the world's largest agencies, start-ups, and well-known brands. Her strategic expertise and perceptive insights drive success for individuals and organizations alike. Jill collaborates with individuals, teams, and organizations to nurture high-performance cultures, enabling leaders to achieve growth. Visit JillGriffinCoaching.com for more details on: Book a 1:1 Career Strategy and Executive Coaching HERE Advising and Consulting Gallup CliftonStrengths Corporate Workshops to build a strengths-based culture Team Dynamics training to increase retention, communication, goal setting, and effective decision-making Keynote Speaking Grab a personal Resume Refresh with Jill Griffin HERE Follow @jillGriffinOffical on Instagram for daily inspiration Connect wit...

Intentional leadership is a powerful way of driving success and inspiring business growth. But how do you lead your team with purpose? In today's episode, Adam Sandman from Inflectra Corporation joins our host, A.J., to discuss this empowering leadership style. They talk about the importance of intentional culture-building, the power of coaching teams, and how value alignment helps drive business in the right direction.About Adam Sandman:Adam is the Founder and CEO of Inflectra - a company that develops software testing tools, application lifecycle management, and automation platforms. He is responsible for product strategy, technology innovation, and business development. Adam's programming journey started when he was ten years old, writing computer games and applications for fun. He then went to Oxford University to study Physics, but after realizing that lab life was not for him, he moved to the US to pursue his other career dreams. One of his first major jobs was for a consulting firm - Sapient, where he was in charge of development with the U.S. Marine Corps. After a while, Adam decided to jump into entrepreneurship, and that's how Inflectra was born. Over the years, the company transitioned from a lifestyle business to a growth-focused enterprise and is now a market leader in software test management and enterprise portfolio management space.Episode highlights: Bootstrapping has its drawbacks and limitations, but this financing model is a great way to build a business with a clear purpose instead of chasing the hot money. When you choose bootstrapping, you're more flexible and independent in your decisions. In addition, as you're growing and scaling up, you're continuously reminded of your WHY, which is the ultimate fuel that drives your business.  (04:06) Transitioning from a founder-led sales model to a team-led model might seem overwhelming, but it's a huge step forward for your business. It allows you to focus on other business growth areas and support your team's professional development as you scale together to new heights. Since sales become a collaborative approach rather than a one-person job, the business can grow sustainably and manageable. (06:53)  It's important to define your sales process before bringing in new salespeople. By optimizing the sales process and making it as clear as possible, you help new hires understand what steps to follow and how their success will be measured. This allows them to do their jobs more effectively and contribute to the overall growth and success of your organization. (08:10) Intentional leadership is about supporting your team as they drive your business forward. That's why coaching is a much better approach than managing in a top-down approach. It helps align their growth with company goals, fosters a purpose-driven environment, and ultimately inspires business growth. (17:00) Every company has its own unique culture, so it's important to recognize the importance of intentional culture-building. By intentionally building a company culture that aligns with your values, you can create a more cohesive and motivated team and enhance employee satisfaction. Satisfied employees who enjoy their work environment tend to remain loyal to the company and its objectives, ultimately resulting in higher productivity and lower turnover. (24:08) Adam's best advice for entrepreneurs:“The culture was more intentional. [...] When we interview people, we interview them both from a skill fit and a core value fit. When we look at how we do business, we try and align our business practices with our values. One of our values is called build for customers, not for Wall Street. And the idea is we want to be around for the long term, build things that the customers find useful, even if it may be against the grain of where the industry has gone.” (24:08) Connect with Adam:  LinkedIn Twitter Instagram Resources Mentioned: Good to Great  Built to Last The Spirit to Serve Marriott's Way Inflectra Website Follow Beyond 8 Figures: Linkedin Twitter Website Affiliate Disclaimer: Some links in this episode are affiliate links. If you make a purchase through these links, we may earn a commission at no extra cost to you. Rest assured, we only promote products/services we believe will benefit your entrepreneurial journey. 

ffodpod.comCC-BY-SA"SCP-326" by Kain Pathos Crow and rewritten by Voct, from the SCP WikiSource: https://scp-wiki.wikidot.com/scp-326Licensed under CC-BY-SAThis show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/5616311/advertisement

ffodpod.comCC-BY-SA"SCP-387" by Archfeared, from the SCP Wiki. Source: https://scp-wiki.wikidot.com/scp-387. Licensed under CC-BY-SA.This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/5616311/advertisement